| Location: | Oklahoma |
|---|---|
| Posted: | Feb 20, 2025 |
| Agency: | VETERANS AFFAIRS, DEPARTMENT OF |
| Type of Contract: | Awards |
| Type of Government: | Federal |
| Category: |
|
| Solicitation No: | 36C |
| Publication URL: | To access bid details, please log in. |
PR-IFCAP: 623-25-2-2455-0001, Equipment Purchase - Pharmacy
PR-IFCAP: 623-25-2-4455-0002, Equipment Purchase – Supply Chain
This procurement is for the Brand Name purchase of the Omnicell Computerized Storage
Cabinets at the Tulsa VA Medical Center (VAMC) in accordance with FAR 13.5 Simplified
Procedures for Certain Commercial Items and specifically FAR 13.501 Special
Documentation Requirements, where acquisitions conducted under Simplified Acquisition
Procedures are exempt from the requirements of FAR Part 6, but still require a justification
using the format of FAR 6.303-2.
The procurement is a firm fixed price contract for supplies and support services for the
supplies. The IGCE for the procurement is $2,418,251.00 based on existing contracts on the
Federal Supply Schedule contract# 36F79723D0073, effective March 1, 2023. Typical
pricing on the contract also includes service support for 1 year after receipt of the equipment.
The Omnicell storage cabinets are smart medical storage units equipped with sensors and technology to monitor inventory, track expiration dates, and streamline medication management. In addition, the computerized cabinets reduce medication errors and missed doses with automated dispensing, and provide real-time inventory tracking to ensure optimal stock levels, allowing staff more time to focus on crucial patient care.
The Period of Performance for this requirement will be from 03/01/2025 through
11/28/2025. Delivery is expected between September through October 2025.
Pharmacy Computerized Cabinet Equipment $1,214,823.85.
Supply Chain Computerized Cabinet Equipment $1,203,427.15.
The total estimated combined value for this contract is $2,418,251.00.
FAR 13.5 Simplified Procedures for Certain Commercial Items. The statutory authority for applying the Simplified Procedures for Commercial Items of FAR 13.5 is 41 U.S.C. § 1901 and is implemented by FAR 13.106-1(b)(2) for restricting competition on this procurement.
Competition is restricted on this procurement for the reason below:
( X ) Only One Responsible Source and No Other Supplies or Services Will Satisfy Agency Requirements
( ) Unusual and Compelling Urgency
( ) Industrial Mobilization, Engineering, Developmental or Research Capability or Expert Services
( ) International Agreement
( ) Authorized or Required by Statute
( ) National Security
( ) Public Interest
Omnicell cabinet component system was developed by Omnicell, which owns proprietary
rights to their products and service offerings. Currently Omnicell storage cabinets are being
used in the Logistics and Pharmacy departments. If the new Tulsa VAMC were to switch to
another brand of computerized supply cabinets, it would greatly increase the complexity of
operation, and maintenance of the database and system. Switching would require the VAMC
to maintain and integrate two different computerized supply cabinets into the local Pharmacy
and Supply Chain Management (SCM) logistics database and system.
The SCM database and system provides services for ten local VAMC services across
nineteen different locations. Having two separate databases would cause confusion and
inefficiency for VAMC staff. It is estimated that operating costs for SCM and Pharmacy is
about 5% of the overall purchase cost.
A different brand of computerized storage cabinets would not only increase operating costs
relating to support, servicing, and maintenance but would also greatly increase training costs.
Training for VAMC staff from another vendor on a different storage cabinet brand would
require about four technicians, estimated to cost about $2,000 a week per technician, plus
classroom costs, training materials, and travel expenses.
Omnicell, provided additional information stating that despite having an NAC/FSS contract, Omnicell's permitted purchase amount is $450,000.00; hence, all purchases over this sum must be competed with TrillaMed, LLC, Omincell's authorized distributor.
Contracting without providing for full and open competition shall not be justified on the basis of lack of advance planning by the requiring activity or concerns related to the amount of funds available (e.g., funds will expire)(See FAR 6.301(c)). To assist you, the following information is provided:
a. Only One Responsible Source – In the case of a follow-on contract for continued development or production of a major system or highly specialized equipment/services, the rationale must first justify the supplies/services as being a “major system” or “highly specialized.” The rationale must then justify “either” substantial duplication of cost to the government that is not expected to be recovered through competition, or unacceptable delays in fulfilling the agency’s requirements, whichever situation applies. If both of these situations apply, the rationale can be based on either of these two situations, or both.
Note: Discuss the use of restrictive brand name descriptions in requirements documentation here under Part V. An acquisition that uses a brand name description or other purchase description to specify a particular brand name, product, or feature of a product, peculiar to one manufacturer does not provide for full and open competition regardless of the number of sources solicited. If there is going to be a brand name used, you will need to justify it and clearly explain why a specific brand produced by a single company is required as opposed to allowing free and open competition. The justification should indicate that the use of such descriptions in the acquisition is essential to the Government’s requirements, thereby precluding consideration of a product manufactured by another company.
(Brand-name or equal descriptions and other purchase descriptions that permit prospective contractors to offer products other than those specifically referenced by brand name, provide for full and open competition and do not require justifications and approvals to support their use.)
When using this exception, the contracting officer (CO) should include one of the following sentences, whichever is applicable: “Accordingly, XYZ Corporation is the only firm capable of providing the supplies and services described in Section III above without the Veteran’s Health Administration experiencing substantial duplication of cost that could not be expected to be recovered through competition,” or “Accordingly, XYZ Corporation is the only firm capable of providing the supplies and services described in Section III above without the Veteran’s Health Administration experiencing unacceptable delays in fulfilling its requirements,” or “Accordingly, XYZ Corporation is the only firm capable of providing the supplies and services described in Section III above without the Veteran’s Health Administration experiencing substantial duplication of cost that could not be expected to be recovered through competition and unacceptable delays in fulfilling its requirements.”
b. Unusual and Compelling Urgency - COs shall contact RPO staff as soon as practicable when contemplating an award under the authority cited in FAR 6.302-2 for J&As requiring HCA or DSPE approval. Provide an explanation why (1) the supplies or services are needed at once because of fire, flood, explosion, or other disaster, or (2) essential equipment or repairs to that equipment are needed at once, e.g., to preclude impairment of healthcare delivery capabilities or mission performance. In other words, identify the anticipated serious injury to the Government, the nature of the urgency, the reasons for it occurring and why it is “urgent and compelling” to preclude adverse impact to Veteran care. Merely citing adverse impact to Veteran care is not in and of itself sufficient reason to use this exception from the requirement to obtain full and open competition. Note that only the minimum quantity required to satisfy the unusual and compelling urgency qualifies for this exception; thus, this exception might not suffice to justify option quantities.
c. Industrial Mobilization; or Engineering, Developmental, or Research Capability - The most important part of justifications citing this authority is demonstrating the need to maintain the capability possessed by the identified source(s). Some form of market survey may be critical in demonstrating the uniqueness of this capability.
d. Authorized or Required by Statute – It is imperative to identify what is being acquired and the applicable statute authorizing other than full and open competition. Note: Some statutes do not require a written J&A.
e. National Security - Provide the minimum essential information needed to establish validity of the justification. This information will make the J&A a classified document. Special handling procedures are required for processing such documentation to the approval authority. Only parties with a “need to know” and the proper level of security clearance should be permitted access to the documentation. Such acquisitions are also exempt from synopsis under FAR 5.202(a)(1).
f. Public Interest - This authority may only be used when none of the other authorities is appropriate and may not be made on a class basis. Provide detail addressing the reasons full and open competition is not in the public interest and why no other authority is appropriate for use. Approval to use this statutory exemption may only be made by a written determination by the Secretary of Veterans Affairs, and with Congressional notification not less than 30 days before award of the contract.
There are two major manufactures of computerized supply storage cabinets; Omnicell and BD Pyxis. Both companies are large businesses who partner with an authorized SDVOSB distributor. Omnicell's authorized distributor is TrillaMed LLC and BD Pyxis's authorized distributor is Four Points Technology. Competition for this requirement is limited to the Brand Name vendors, Omnicell, Inc. and TrillaMed, LLC. As there are no two Small Businesses capable of providing these products, this acquisition will be competed as Restricted.
Omnicell was originally contacted by the Tulsa VA Medical Center (VAMC) back in March
of 2024, and provided their price estimate on May 30, 2024. On June 26, 2024, Omnicell
provided an Authorized Vendor letter to contracting stating that TrillaMed, LLC is the only
authorized business to provide their products. All other services will be Sole Sourced to
Omnicell, Inc.
Include a statement by the CO that the anticipated cost will be considered fair and reasonable and provide the basis for this determination. The steps that will be taken to ensure the final contract price will be fair and reasonable are also described here. Describe the extent of cost or price analysis anticipated including the requirements for certified cost or pricing data, technical evaluations, and audits (FAR 6.303-2(b)(7)).
In consideration of all the information obtained, both Omnicell, Inc. and TrillaMed, LLC, proposals would be based on Federal Supply Schedule pricing, which has been determined to be fair and reasonable.
An additional search was conducted in VetBiz using the NAICS and keyword returned zero results.
Information provided by Omnicell via email stated that Omnicell products are U.S. made with the exception of the third-party software (Windows 10, etc.).
Discuss consideration to BAA/TAA/Exceptions to BAA (See FAR 25).
When citing the authority of only one (or a limited number of) responsible source(s), use the following sentence: “As described in Section 6 above, market research, in accordance with FAR Part 10, was conducted by synopsis of the proposed acquisition, advising industry of the pending acquisition and soliciting inquiries from interested parties.”
When other exceptions from the requirement to obtain full-and-open competition are relied upon, the market research might be limited to an examination of the acquisition history and experience with the marketplace under previous acquisitions for the same or similar items. In all instances a current check of VIP shall be performed.
Full and Open Competition is not feasible since Omnicell, Inc. is the sole propriator and restricts who can sell their products. As the result, competition will be restricted between Omnicell, Inc. and their authorized distributor, TrillaMed, LLC.
Omnicell, Inc.
Bradley Galbreath
817-239-0308
TrillaMed, LLC
Tejas Smart
248-203-9734
Acquisitions that require brand name specific Omnicell products can be met by using their
FSS contract 36F79723D0073, up to the maximum allowable purchase amount of
$450,000.00. Purchases over this sum must be competed with TrillaMed, LLC, Omnicell's
only authorized distributor.
| Apr 18, 2025 | [Combined Synopsis/Solicitation (Original)] Cancellation of RFQ 36C25625Q0523 Restroom Janitorial Services |

With GovernmentContracts, you can: